NEW DELHI: The Subject Expert Committee of the
Central Drug Standard Control Organization on Friday has held that the data
provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not
sufficient for grant of emergency use approval and has asked for more
information, top sources said. (IANS)